-66e14b5de0160.png)
11 September 2024
On September 17-20, 2024, the International Scientific Conference BioGENext: Biomedical research and development as the basis for the medicine of the future.
BioGENext is the first conference in Ukraine dedicated to the research and development of next generation therapeutics, which is organized as a partnership event by the R&D Center of YURIA-PHARM Group of Companies and the Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine.
BioGENext conference aims to bring together all industry players: scientists, educators, representatives of pharmaceutical companies and government institutions to jointly form an effective ecosystem for biomedical research in Ukraine, as well as to direct advanced expertise to develop and bring innovative therapeutic products to market.
The Kyiv Academic University and Academ.City will conduct a series of workshops.
Date: September 18, 2024 | Time: 9:00-10:30
Discover the grant programs and competitions available for 2024-2025 that will empower Ukrainian researchers to conduct groundbreaking studies and drive innovation. This workshop will provide essential insights to help you secure the resources necessary for your projects.
Date: September 20, 2024 | Time: 9:00-10:00
Explore the journey of transforming research into market-ready products. This workshop will guide you through key stages of development, from idea conception to commercialization, helping you identify challenges, assess market potential, and attract investment.
Also, representatives of the UAC and Academ.City will take part in the panel discussion and will be glad to see you at the consultation table.
The main objectives of the conference are:
- To create a platform for interaction between the main stakeholders in the field of biomedical research and biopharmaceutical development;
- Encourage high-quality biomedical and biopharmaceutical research in Ukraine by demonstrating the latest global trends in the industry;
- Promote cooperation and joint projects between scientific groups and pharmaceutical R&D at the national and international levels;
- Encourage the active development of educational programs in biomedicine and biotechnology in universities to ensure high-quality training of future specialists.
Thematic sections of the conference are devoted to the following areas:
- Development of nucleic acid-based therapies
- Development of recombinant proteins and monoclonal antibodies
- Gene editing technologies and their potential application in medicine
- Bioinformatics and AI in biomedical research and development
- Biomarkers and tools for molecular diagnosis of diseases
- Other translational biomedical research
